NeoGenomics, Inc.

Healthcare · Diagnostics & Research · United States

Last price 17.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.30B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and ge...